Nonprotein-bound iron in postasphyxial reperfusion injury of the newborn

Pediatrics

Volumn 98, Issue 5, 1996, Pages 883-889

  Dorrepaal, Caroline A ^a   Berger, Howard M ^a   Benders, Manon J N L ^a   Van Zoeren Grobben, Diny ^a   Van De Bor, Margot ^a   Van Bel, Frank ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

birth asphyxia; newborn; nonprotein bound iron; reperfusion injury

Indexed keywords

IRON;

ARTICLE; BRAIN HYPOXIA; BRAIN INJURY; BRAIN MATURATION; FOLLOW UP; HUMAN; IRON BLOOD LEVEL; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; NERVE CELL DIFFERENTIATION; NEWBORN; PRIORITY JOURNAL; PROGNOSIS; REPERFUSION INJURY;

ASPHYXIA NEONATORUM; BRAIN DAMAGE, CHRONIC; CREATININE; HUMANS; INFANT, NEWBORN; IRON; LIPID PEROXIDATION; LIVER; REGRESSION ANALYSIS; REPERFUSION INJURY; UREA; URIC ACID;

EID: 0029958538     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Volpe JJ. Neurology of the Newborn. 3nd ed. Philadelphia: WB Saunders; 1995:211-369
2. Freeman JM, Nelson KB. Intrapartum asphyxia and cerebral palsy. Pediatrics. 1988;82:240-249
3. Saugstad OD. Oxygen toxicity in the neonatal period. Acta Paediatr. 1990;79:881-892
4. Traystman RJ, Kirch JR, Koehler RC. Oxygen radical mechanisms of brain injury following ischemia and reperfusion. J Appl Physiol. 1991;71: 1185-1195
5. Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem. 1992;59:1609-1623
6. McCord J. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med. 1985;312:159-163
7. Pazdernic TL, Layton M, Nelson SR, Samson FE. The osmotic/calcium stress theory of brain damage: are free radicals involved? Neurochem Pathol. 1992;17:11-21
8. Yokoyama Y, Beckman JS, Beckman TK, et al. Circulating xanthine oxidase: potential mediator of ischemic injury. Am J Physiol. 1990;258: G564-G570
9. Gutteridge JMC, Quinlan GJ. Antioxidant protection against organic and inorganic oxygen radicals by normal human plasma: the important primary role for iron-binding and iron-oxidising proteins. Biochem Biophys Acta. 1992;1159:248-254
10. Gutteridge JMC, Halliwell B. Radical-promoting loosely bound iron in biological fluids and the bleomycin assay. Life Chem Rep. 1987;4:113-142
11. Moison RWM, Palinckx JJS, Roest M, Houdkamp E, Berger HM. Induction of lipid peroxidation of pulmonary surfactant by plasma of preterm babies. Lancet. 1993;341:79-82
12. Evans PJ, Evans R, Kovar IZ, Holten AF, Halliwell B. Bleomycin-detectable iron in plasma of premature and full term newborns. FEBS Lett. 1992;303:210-212
13. Gutteridge JMC, Halliwell B. Bleomycin assay for catalytic iron salts in body fluids. In: Greenwald RA, ed. CRC Handbook of Methods for Oxygen Radical Research. Boca Raton, FL: CRC Press; 1985:391-394
14. Asakawa T, Matsushita S. Coloring conditions of thiobarbituric acid test for detecting lipid hydroperoxides. Lipids. 1980;15:137-140
15. Thurnham DI, Koottathep S, Adelekan DA. Chain-breaking antioxidants in the blood of malaria infected children. In: Rice Evans C, Dormandy T, eds. Free Radicals: Chemistry, Pathology and Medicine. London, England: Richelieu Press; 1988:161-185
16. Touwen BLC, Growth and development of the central nervous system (in Dutch). In: Koppens PW, ed. Leerboek voor de gezondheidszorg. Assen, The Netherlands: Van Gorcum; 1982
17. Gesell A, Amatruda CS. In: Kobboch H, Pasamaninck B, Hagerstown ND, eds. Developmental Diagnosis. The Evaluation of Normal and Abnormal Neuropsychologic Development in Infancy and Early Childhood. Hagerstown, MD: Harper and Row; 1974
18. Lindeman JHN, Houdkamp E, Lentjes EGWM, Poorthuis BJ HM, Berger HM. Limited protection against iron-induced lipid peroxidation by cord blood plasma. Free Radical Res Commun. 1992;16:285-294
19. Gutteridge JMC, Hou Y. Iron complexes and their reactivity in the bleomycin assay for radical-promoting loosely-bound iron. Free Radical Res Commun. 1986;2:143-151
20. Siesjo BK. Acidosis and ischemic brain damage. Neurochem Pathol. 1988; 9:31-88
21. Biemond P, Swaak AJG, Beindorff CM, Koster JF. Superoxide-dependent and -independent mechanisms of iron mobilisation from ferritin by xanthine oxidase. Biochem J. 1986;239:169-173
22. Halliwell B, Aruoma OI, Mufti G, Bomford A. Bleomycin-detectable iron in serum from leukaemic patients before and after chemotherapy. FEBS Lett. 1988;241:202-204
23. Lentjes EGWM, Lindeman JHN, Van De Bent W, Berger HM. Measured versus calculated iron binding capacity in plasma of newborns. Ann Clin Biochem. 1995;32:478-481
24. Halat G, Chavko M, Lucakova N, Kluchova D, Marsala J. Effect of partial ischemia on phospholipids and postischemic lipid peroxidation in rabbit spinal cord. Neurochem Res. 1989;14:1089-1097
25. Willmore LJ, Triggs WJ, Gray JD. The role of iron induced hippocampal peroxidation in acute epileptogenesis. Brain Res. 1986;382:422-426
26. Smith C, Mitchinson MJ, Aruoma OI, Halliwell B. Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions. Biochem J. 1992;286:901-905
27. Van Bel F, Dorrepaal CA, Wagenaar I, et al. Prevention of free radical mediated postasphyxial brain injury by N-ω-nitro-L-arginine (NLA). Pediatr Res. 1995;37:387A
28. Palmer C, Pavlick G, Karley D, Robberts RL, Connor JR. The regional localization of iron in the cerebral cortex of the immature rat: relationship to hypoxic-ischemic (HI) injury. Pediatr Res. 1993;33:375A
29. Gutteridge JMC. Iron and oxygen radicals in brain. Ann Neurol. 1992; 32:S16-21
30. Gutteridge JMC. Ferrous ions detected in cerebrospinal fluid by using bleomycin and DNA damage. Clin Sci. 1992;82:315-320
31. Lesnefsky EJ, Ye J. Exogenous intracellular, but not extracellular, iron augments myocardial reperfusion injury. Am J Physiol. 1994;266: H384-H392
32. Panter SS, Braughler JM, Hall ED. Dextran-coupled deferoxamine improves outcome in a murine model of head injury. J Neurotrauma. 1992;9:47-53
33. Rosenthal RE, Chanberbhan R, Marshall G, Fiskum G. Prevention of post-ischemic brain lipid conjugated diene production and neurological injury by hydroxyethyl starch-conjugated deferoxamine. Free Radical Biol Med. 1992;12:29-33
34. Lindeman JHN, Van Zoeren-Grobben D, Schrijver J, Speek AJ, Porthuis BJHM, Berger HM. The total free radical trapping ability of cord plasma in preterm and term babies. Pediatr Res. 1989;26:20-24
35. Berger HM, Mumby S, Gutteridge JMC. Ferrous ions detected in iron-overloaded cord blood plasma from preterm and term babies: implications for oxidative stress. Free Radical Res. 1995;22:555-559
36. Halliwell B. Protection against tissue damage in vivo by desferrioxamine. What is its mechanism of action? Free Radical Biol Med. 1989;7: 645-651
37. deLemos RA, Roberts RJ, Coalson JJ, deLomos JA, Null DM, Gerstmann DR. Toxic effects associated with the administration of deferoxamine in the premature baboon with hyaline membrane disease. Am J Dis Child. 1990;144:915-919
38. Lindeman JHN, Lentjes EGWM, Houdkamp E, van Zoeren-Grobben D, Schrijver J, Berger HM. Effect of an exchange transfusion on plasma antioxidants in the newborn. Pediatrics. 1992;90:200-203
39. Halliwell B, Chirico S. Lipid peroxidation: its mechanism, measurement, and significance. Am J Clin Nutr. 1993;57(suppl):715S-25S